UPB
Upstream Bio, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
E. Rand Sutherland
IPO Date
2024-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Upstream Bio, Inc.
CEO
E. Rand Sutherland
IPO Date
2024-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 2,095 |
| $6.10 |
| 17 Jun 2026 | Houghton Adam | Chief Business Officer | S-Sale | Disposed | 700 | $6.10 |
| 17 Jun 2026 | Deykin Aaron | Chief Medical Officer | S-Sale | Disposed | 895 | $6.10 |
| 17 Jun 2026 | Ambrose Allison | General Counsel | S-Sale | Disposed | 477 | $6.10 |
| 11 Jun 2026 | Ruddy Marcella K. | director | A-Award | Acquired | 17,096 | $6.69 |
| 11 Jun 2026 | Renaud Ronald C JR | director | A-Award | Acquired | 17,096 | $6.69 |
| 11 Jun 2026 | Fleming Harold Edward | director | A-Award | Acquired | 17,096 | $6.69 |
| 11 Jun 2026 | Beckman Daniella | director | A-Award | Acquired | 17,096 | $6.69 |
| 11 Jun 2026 | Ratcliffe Liam | director | A-Award | Acquired | 17,096 | $6.69 |